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Abstract
Background: Early lifetime exposure to dietary or supplementary vitamin D has been predicted
to be a risk factor for later allergy. Twin studies suggest that response to vitamin D exposure might
be influenced by genetic factors. As these effects are primarily mediated through the vitamin D
receptor (VDR), single base variants in this gene may be risk factors for asthma or allergy.
Results: 951 individuals from 224 pedigrees with at least 2 asthmatic children were analyzed for
13 SNPs in the VDR. There was no preferential transmission to children with asthma. In their
unaffected sibs, however, one allele in the 5' region was 0.5-fold undertransmitted (p = 0.049),
while two other alleles in the 3' terminal region were 2-fold over-transmitted (p = 0.013 and 0.018).
An association was also seen with bronchial hyperreactivity against methacholine and with specific
immunoglobulin E serum levels.
Conclusion: The transmission disequilibrium in unaffected sibs of otherwise multiple-affected
families seem to be a powerful statistical test. A preferential transmission of vitamin D receptor
variants to children with asthma could not be confirmed but raises the possibility of a protective
effect for unaffected children.
Background
Early exposure to dietary and supplementary vitamin D
has been predicted to be a risk factor for later allergy and
asthma [1]. Supported by in vitro [2] and in vivo studies
[3], also epidemiological studies [4,5] report a positive
association between supplementary vitamin D use and
later allergy [6].
Vitamin D has been used for many years in various doses
and preparations to prevent rickets, a disease usually
induced by poor dietary calcium intake and sun depriva-
tion. It seems that widespread "historical" rickets in indus-
trial countries was also a genetic disease. A formal twin
analysis yielded a 91% concordance rate in monozygotic
twins compared to 23% in dizygotic twins [7]. Also a very
recent study of baseline gene expression in lymphoblast-
oid cell-lines found the expression of at least four vitamin
D related genes as a heritable trait [pers. comm. Monks
2004], which also makes a genetically determined vitamin
D sensitivity likely. It may be speculated that common
rickets is the low sensitivity form (in the absence of proper
endogenous vitamin D production), and allergy the high
sensitivity form (in the presence of high oral vitamin D
exposure).
The active vitamin D metabolite 1,25(OH)2D3 binds to
nuclear vitamin D receptor (VDR), which exists from
under 500 to over 25,000 copies / cell in many human
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tissues including thymus, bone marrow, B and T cells and
lung alveolar cells [8]. The gene for VDR was cloned in
1988, it consists of 9 exons with at least 6 isoforms of exon
1 and spans 60–70 kb of genomic sequence (Fig. 1) [8].
The VDR is also a first-order positional candidate as nearly
all asthma and allergy linkage studies found linkage on
chromosome 12q [9,10]. While an own study of a single
Fok1 restriction site (that alters the ATG start codon in the
second exon of the VDR) in asthma families did not find
an association [11], positive association of several VDR
variants with asthma has been shown in the meantime by
two U.S. [12] as well as one Canadian study [13].
So far, dbSNP catalogued 117 SNPs in the VDR when a
resequencing approach of the VDR published in June
2004 found 245 SNPs [14]. In this study three LD blocks
were localized. Block "A" at the 3' end of exon 9 spans
approximately 10.5 kb. VDR exons 3 – 9 are situated in
block "B", which spans 40.8 kb. A 5.7 kb LD-breaking spot
separates blocks "A" and "B", while blocks "B" and "C" are
separated by a 1.3 kb LD-breaking spot; this region also
includes VDR exon 2 and the commonly studied FokI
SNP. All three LD blocks have now been covered by addi-
tional SNPs in our asthma family sample.
Results
The sample analyzed here consisted of 951 individuals
from 224 pedigrees contributing 11,383 genotypes.
Mean pedigree size was 4.4; the number of phase-known
individuals ranged from 221 to 305 (with the exception of
rs2853563) in affected, and from 24 to 41 in the unaf-
fected, children. Except for rs2853563, the minor allele
frequency always exceeded 19%. In two families both par-
ents had asthma, in 82 only one parent had asthma and
in 140 families both parents were disease-free.
Of the markers tested, only marker rs2239186 showed a
slightly reduced transmission ratio in asthmatic children
(0.8, P = 0.073). In unaffected children three markers
showed significantly altered ratios: 0.5 for hCV2880804,
and 2.0 and 1.9 in rs1989969 and rs2853564, respec-
tively. Excess transmission was generally more pro-
nounced in unaffected children (Fig. 2), however, the
Structure of the vitamin D receptor [40, 41] Figure 1
Structure of the vitamin D receptor [40, 41]. Upper: LD blocks in Caucasians [14] where blocks "C" and "A" extend to both 
sides. In Africans block "C" is split into 3 parts, "C1", "C2" and "C3". Middle: Exon structure including several SNP variants 
examined in about 100 disease-association studies. Lower: Aligned protein domains, DNA binding, hinge and ligand binding 
region including phosphorylation sites.
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three significant associations would also not persist if
adjusted for multiple testing with the method described
by Bonferroni.
The TDTDS test as a global family test seems to capture the
information both from affected and unaffected children,
with four SNPs being at least marginally significantly
associated at the 5% level. As unaffected children might be
the younger children (that still have not developed a phe-
notype), the age distribution of affected and unaffected
children was also compared (Fig. 3) but no difference was
found. Affected and non affected children, however, show
several other differences, all known as risk factors and
symptoms for asthma: There are more boys in the affected
group (57,6% vs. 36,1%), they are more often exposed to
indoor environmental tobacco smoke (43.0% vs. 31.7%)
and they are suffering more frequently from eczema
(43,0% vs. 26,9%). Their average log(IgE) values are
higher (7,7 kU/l vs. 5,8 kU/l), their forced 1 second capac-
ity FEV1 is lower (2387 ml vs. 2625 ml) together with the
forced vital capacity (2876 vs. 2998).
Bronchial hyper-reactivity (BHR), measured as quantita-
tive trait locus (QTL) by using the slope of the dose-
response curve in a standardized methacholine challenge
protocol, also indicated an association with the same
three SNPs identified in unaffected sibs. Further dichot-
omizing BHR by comparing the upper versus all other
quartiles also yielded significant associations
(hCV2880804, P = 0.005, rs1989969 P = 0.001,
rs2853564 P = 0.001). The sum score of all specific IgE
serum levels (RAST) was associated with markers
rs1989969 (P = 0.021) and rs2853564 (P = 0.018), while
total IgE was not found to be associated.
Table 2 summarizes the LD structure of all SNPs in the
German families. LD was generally low, except for three
SNPs on block "B". SNP rs2853563 probably does not
interrupt block "B", as might be concluded from table 2,
as this marker has a very low minor allele frequency (table
1). The overall low LD was very similar in the Swedish and
Turkish subgroups of our families and are in line with
recently published data [12-14]. The association seen for
the two SNPs at the 3'-terminal region is probably influ-
enced by the high LD between these two SNPs.
Finally, a 4-locus haplotype was constructed of those
SNPs associated in the TDTDS. Again, no significant trans-
mission distortion was found in affected children, while
Excess transmission of VDR-SNPs in asthma families Figure 2
Excess transmission of VDR-SNPs in asthma families. Blue 
bars indicate transmission to affected children, grey bars 
transmission to unaffected children.
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Age distribution in children with, blue box (left), and without 
asthma, grey box (right).
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one haplotype showed a 5.1-fold over-transmission in
unaffected children (P = 0.009).
Discussion
This study addresses a previously described association of
VDR SNPs with asthma and related phenotypic traits.
Although a preferential transmission of vitamin D recep-
tor variants to children with asthma could not be con-
firmed, it raises the possibility of a protective effect in
unaffected children. Although the effect is rather moder-
ate, several SNPs support this association. If any, the
association is probably more related to RNA turnover
than to a structural modification of the receptor as there
was no association with LD block "B" that codes for the
translated exons. Gene expression can be varied over a
100-fold range by subtle modifications of the 3'-terminal
sequence [15], which will requires further research on the
function of these allelic variants in target tissues.
This notion is partially in contrast with a previous study of
7 VDR SNPs in the CAMP (Childhood Asthma Manage-
ment Program) study of 582 nuclear families where SNP
rs7975232 (akin ApaI) in intron 8 showed a highly signif-
icant effect [12]. A confirmation study by the same group
in a case-control sample of the Nurses' Health Study NHS
[12] also associated asthma with rs3782905 (intron 2, P =
0.02), rs2239185 (intron 3, P = 0.02) and rs731236
(Ile352Ile, P = 0.03). A study of 223 independent Cana-
dian families reported six out of twelve SNPs to be associ-
ated with asthma (rs3782905, rs1540339, rs2239182,
rs2239185, BsmI, ApaI, TaqI), most of these on block "B".
As none of these SNPs was giving rise to an amino acid
change the authors speculated about an intronic regula-
tory SNP or one or more functional variants at the 3' end
of the VDR locus.
It is unlikely that increased or decreased vitamin D sensi-
tivity is simply mediated by a genetic variation in the
Table 1: Transmission disequilibrium of 13 VDR-SNPs in affected and unaffected children. P-values < 0.05 are indicated in bold.
asthma no asthma
LD block * dbSNP allele chr12 (bp) geno-types freq (%) T UT T/UT P T UT T/UT P P TDTDS
A hCV2880804 C 47954855 918 28 170 178 1,0 0,668 18 33 0,5 0,049 0,055
-- rs2228570 T 47977944 724 35 159 150 1,1 0,609 21 12 1,8 0,117 0,079
? rs3819545 C 47981753 912 38 186 191 1,0 0,797 25 31 0,8 0,423 1,000
B rs3782905 G 47982914 934 32 201 174 1,2 0,163 26 27 1,0 0,891 0,388
? rs2853563 G 48248398 661 97 20 24 0,8 0,547 -- -- -- -- --
B rs731236 C 48251417 923 37 202 206 1,0 0,843 25 29 0,9 0,586 0,767
B rs1544410 A 48252495 896 37 190 186 1,0 0,837 23 26 0,9 0,668 1,000
B? rs2239185 C 48257219 903 49 198 214 0,9 0,431 29 24 1,2 0,492 0,650
? rs987849 C 48267336 825 45 164 169 1,0 0,784 28 18 1,6 0,140 0,173
B rs1540339 A 48269986 916 36 189 187 1,0 0,575 25 27 0,9 0,782 0,706
? rs2239186 C 48282070 929 19 116 145 0,8 0,073 20 18 1,1 0,746 0,189
C rs1989969 T 48290670 922 43 204 198 1,0 0,765 39 20 2,0 0,013 0,025
C rs2853564 C 48291147 920 44 196 201 1,0 0,802 38 20 1,9 0,018 0,021
*according to reference [15]
Table 2: D' matrix of 13 VDR-SNPs in German parents. D' values > = 0.69 are indicated in bold.
rs2228570 rs3819545 rs3782905 rs2853563 rs731236 rs1544410 rs2239185 rs987849 rs1540339 rs2239186 rs1989969 rs2853564
hCV2880804 0,01 0,02 -0,04 0,05 0,01 0,01 -0,02 -0,01 0,05 0,02 -0,27 -0,27
Rs2228570 0,02 -0,03 0,01 0,06 0,02 -0,01 -0,03 -0,03 -0,10 0,12 0,13
Rs3819545 -0,53 0,08 -0,41 -0,41 0,26 0,25 0,85 0,58 -0,02 -0,02
Rs3782905 -0,08 0,53 0,55 -0,44 -0,45 -0,45 -0,33 0,05 0,05
Rs2853563 -0,14 -0,16 0,20 -0,10 0,19 -0,01 -0,07 -0,08
Rs731236 0,98 -0,76 -0,69 -0,46 -0,32 0,07 0,05
Rs1544410 -0,76 -0,69 -0,46 -0,33 0,06 0,05
Rs2239185 0,85 0,28 0,33 -0,06 -0,05
Rs987849 0,22 0,40 -0,02 -0,01
Rs1540339 0,58 -0,07 -0,07
Rs2239186 -0,11 -0,11
Rs1989969 0,98BMC Genetics 2005, 6:2 http://www.biomedcentral.com/1471-2156/6/2
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VDR. Vitamin D requires several enzymatic steps to be
activated, transported and degraded; receptor signalling
requires several co-factors and all of these may contribute
additive or multiplicative effects on vitamin D sensitivity.
The co-activator retinoic acid receptor RXR may itself
affect Th1 and Th2 development [16]. Other transcription
factors involved are SRC/p160, CBP and p300 [17]. The
DRIP complex attaches to the VDR/RXR complex and
binds to vitamin D responsive elements (VDRE) through
histone acetyltransferase activity. Importantly, some of
the vitamin D regulated genes are also located in allergy
linkage regions. The renal 1-α-hydroxylase (12q13) and
the 24-hydroxylase (20q13), as well as RXR (6p21), are all
positional candidates. RXR has already been tagged by a
SNP in a previous study [18] and also 3 SNPs in CYP24A1
(rs751089, rs2296241 and rs2248137) were significantly
associated with asthma (unpublished own observation).
CYP24A1 is particular interesting as it is the major enzyme
of the degradation pathway that showed a 97-fold
increase after vitamin D treatment of rats [19] or 12-fold
increase in a human colon cancer cell line [20].
The number of genes regulated by vitamin D has been
recently extended beyond those genes with known VDRE
promoter motifs (calbindin, PTH, PTHRP, ITGB3, OC,
GH, osteopontin, osteocalcin, c-fos, IL-2Rβ, NFκB,
sCD23) to another 150 up- and down-regulated regulated
genes [19-23]. The interaction of genetic variants in the
VDR and other positional, as well as functional, candidate
genes is therefore a current research topic. So far, only two
gene associations have been published: Vitamin D bind-
ing protein (GC*2 and GC*1F) was associated with an
increased risk for COPD [24,25] and osteopontin (OPN
C8090T and T9250C) with increased total IgE in asth-
matic patients [26].
In addition to its biological context, this study also has
some implications on the statistical analysis as the rather
low number of unaffected sibs seemed to contribute to a
few positive associations. Despite enormous efforts to
map complex genetic diseases, SNP association studies are
often lacking power [27]. Linkage studies in affected sib
pairs have been preferably used to map complex diseases
to chromosomal regions [9], while "no substantial study
of normal sib-pairs has been undertaken, making this
family of surveys one of the largest undertaken in the
absence of controls" [28] although unselected affected sib
pairs tend to share more than half of their alleles [29].
This omission is even more remarkable as discordant sib
pairs (DSP) have been shown to be a more powerful alter-
native [30]. Risch proposed to test DSP in the top ten and
bottom ten percent distribution of quantitative traits, as
pairs with intermediate values (between the 30th and 70th
percentiles) did not provide much information for link-
age analysis [31]. Although the DSP concept was appeal-
ing from a theoretical standpoint, it turned out that there
are disadvantages for practical reasons. It requires a large
amount of individuals to be screened, which might be the
reason that the DSP approach has not received the
expected attention except for a few studies (for a summary
see [31]).
Transmission disequilibrium testing of unaffected child –
parent trios originating from families with another two
affected offsprings, may be a powerful alternative. As there
is a strong ascertainment bias of these families toward a
genetic risk, as well as a disease causing environmental
factor, being unaffected is an extreme phenotype ("being
sane in an insane world"). The transmission to unaffected
children can be seen as an independent cross-match to the
transmission to affected children. The high power of test-
ing unaffected sibs has already been predicted on theoret-
ical grounds [32]. The number of DSPs required to
achieve 80% power (with a difference in the allele
frequency of 15% and λs of 3.2) has been estimated to be
approx. 250 [33]. A sample size of 1,500 families was esti-
mated by including two affected and one unaffected chil-
dren [34]. In this study already 50 DSPs were sufficient to
show a significant distortion in the allele transmission.
Non-paternity as a reason for discordant traits [35] is
unlikely as nearly all families were included in a previous
genome-wide scan.
Conclusions
The transmission disequilibrium in unaffected sibs in oth-
erwise multiple-affected families seems to be a powerful
test. A preferential transmission of vitamin D receptor
variants to children with asthma could not be confirmed
but raises the possibility of a protective effect in unaf-
fected children.
Methods
Study population
The German asthma sib pair families were collected in 26
paediatric centres in Germany and Sweden for an initial
genome-wide linkage scan. In these families at least two
children were required with confirmed doctor-diagnosed
asthma, while prematurity or low birth weight of the chil-
dren were excluded, along with any other severe pulmo-
nary disease. All affected children should have after their
3rd birthday a history of at least three years of recurrent
wheezing and should not have any other airway disease
diagnosed. Unaffected siblings were also sampled if they
were at least 6 years old, eligible for pulmonary function
testing and did not have doctor-diagnosed asthma.
On the first home visit a complete pedigree of the family
was drawn and information collected in a questionnaire.
Participants were examined for several associated pheno-
types. Pulmonary function tests were performed by forcedBMC Genetics 2005, 6:2 http://www.biomedcentral.com/1471-2156/6/2
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flow volume tests and bronchial challenge was done by
methacholine.
Briefly, pulmonary function tests were performed by
forced expiration in a sitting position using a nose-clip.
Forced flow volume tests were performed until three
reproducible loops were achieved. Of these the trial with
the maximum sum of FVC and FEV1.0 was used for the
analysis. Bronchial challenge with methacholine was
done with increasing doses of 0, 0.156, 0.312, 0.625,
1.25, 2.5, 5, 10, 25 mg/ml during 5 consecutive breaths
with 14 mg delivered from a de Vilbiss 646 nebulizer
chamber by using a breath-triggered pump ZAN 200 (Zan,
Oberthulpa, Germany). The provocation was stopped
either with the occurrence of symptoms or a fall of 20%
from the baseline FEV1.0 and the slope of the dose-
response curve calculated.
Total IgE was determined with an ELISA (Pharmacia Diag-
nostics, Uppsala, Sweden). The allergens tested were birch
(betula verruscose) ALK SQ108, hazel (corylus avellana)
ALK SQ113, the herbs ribworth (plantago lanceolata) ALK
N342 and mugwort ALK SQ312, mixed grass ALK SQ299,
dust mite dermatophagoides farinae ALK SQ 504, dermat-
ophagoides pteronyssimus ALK SQ 503, cat dander ALK
SQ555 and dog dander ALK SQ 553, and fungi (aspergil-
lus fumigatus ALK N405 and alternaria alternata ALK
N402), which were bought in one batch and stored at
+5°C until analysis.
The original family collection [36] has been expanded
since 1994 to a larger sample, of which 218 families were
available in 2002 for a complete genome scan. The con-
secutive families were tested with the same protocol as
described earlier [36] except that the time-consuming
methacholine challenge protocol was omitted. Excluded
from the final sample were individuals with incomplete
data, missing DNA samples, identical twins and all
probands with more than 2 non-segregating out of 408
microsatellite markers. Another 6 families could be
included in this analysis, resulting in a final sample of 224
families. Each study participant, including all children,
signed a consent form. All study methods were approved
in 1995 by the ethics commission of "Nordrhein-West-
falen" and again in 2001 by "Bayerische Landesärztekam-
mer München".
DNA preparation and genotyping
DNA was isolated from peripheral white blood cells using
Qiamp (Qiagen, Germany) or Puregene isolation kits
(Gentra Systems, Minneapolis, MN, USA). From the VDR
we selected 16 SNPs where 13 could finally be analyzed.
They had to be polymorphic, complete, received a high
calling score, passed paternity checks and were in Hardy-
Table 3: Primer used for genotyping
SNP left primer right primer extension primer stop mix
hCV2880804 ACGTTGGATG-
CTGGGATACTTCTGAGAGTG
ACGTTGGATG-
TTTTCCCTGGAAAGTTTGGG
CCATTGTCCTGGTATAACCA ACG
rs2228570 ACGTTGGATG-
TCAAAGTCTCCAGGGTCAGG
ACGTTGGATG-
AGACCTCACAGAAGAGCACC
CCCTGCTCCTTCAGGGA ACG
rs3819545 ACGTTGGATG-
AATGGTGGTTACTGCAGCTC
ACGTTGGATG-
GAAACCAGTCCTCTGTCATG
TAGGTTCGGTCTTTGGCT ACG
rs3782905 ACGTTGGATG-
GGGTCTCAAATTCTTAATGAG
ACGTTGGATG-
AAACTAGCAGAAAGAGGCAG
GTGGGAGGGAGTGCTGA ACT
rs2853564 ACGTTGGATG-
CTGCATTGCTCCTGACTTAG
ACGTTGGATG-
AGGTAGCTTAGCTCTGAGTC
TTTCTGCAACCCTAAGCC ACT
rs731236 ACGTTGGATG-
TGTGCCTTCTTCTCTATCCC
ACGTTGGATG-
TGTACGTCTGCAGTGTGTTG
CGGTCCTGGATGGCCTC ACT
rs1544410 ACGTTGGATG-
TAGATAAGCAGGGTTCCTGG
ACGTTGGATG-
AATGTTGAGCCCAGTTCACG
AGCCTGAGTATTGGGAATG ACG
rs2239185 ACGTTGGATG-
CAATTCCAGTCACATCTCGG
ACGTTGGATG-
CCTGTGTGACATTTACACCC
CCCTCCTCTGTCTTCAC ACT
rs987849 ACGTTGGATG-
GAATAGTGCCTTATAGATAG
ACGTTGGATG-
AGCTAGAAGTTCTGGTGATC
GAAATATTCGTAATGCTGGA
T
ACT
rs1540339 ACGTTGGATG-
TCACACACATTCTCAGTGGG
ACGTTGGATG-
TTTGCAGAGGCTGTCTTCTC
GTTGGTGCCCACCCTAA ACG
rs2239186 ACGTTGGATG-
GTCCACAGTGACTATAGACC
ACGTTGGATG-
AAGAAGGAGAAGCAGGCATC
CAGGGGTGGAAGAAGAGGA
G
ACT
rs1989969 ACGTTGGATG-
TGTATGCAGAGCTTAGCAGG
ACGTTGGATG-
TTTCAGAGGTCAGAGGTGAC
GTCAGAGGTGACATCCAG ACT
rs2853564 ACGTTGGATG-
CTGCATTGCTCCTGACTTAG
ACGTTGGATG-
AGGTAGCTTAGCTCTGAGTC
TTTCTGCAACCCTAAGCC ACTBMC Genetics 2005, 6:2 http://www.biomedcentral.com/1471-2156/6/2
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Weinberg equilibrium. The following three markers have
been excluded from the analysis: rs2239179 (contami-
nant in mass spectrum peak), rs2853559 (Hardy-Wein-
berg disequilibrium, paternity errors) and rs797523
(typing error in primer sequence).
Genotyping was performed using MALDI-TOF mass spec-
trometry of allele-specific primer extension products
(Table 3) generated from amplified DNA sequences (Mas-
sARRAY, SEQUENOM Inc., San Diego, CA, USA). Primers
were obtained from Metabion GmbH (Planegg-Martin-
sried, Germany).
Data handling and statistical analysis
Clinical data and genotypes were transferred to a SQL
2000 database by using Cold Fusion 4.0 scripts. Statistical
analyses were performed using R 1.8.1 [37] by accessing
the database with the RODBC module. For each SNP, the
distribution of genotypes in pseudo-controls created by
combining the parental alleles not transmitted to asthma
children was tested by a χ2-test as well as the transmission
to their unaffected sibs. An extension of the classical TDT
[34] was also implemented that incorporates effectively
both affected and unaffected children (TDTDS). The stand-
ardized linkage disequilibrium coefficient D' and the cor-
relation coefficient R2 were calculated for each pair of
SNPs in parents by using the R package "genetics". All
analyses were cross-checked by using SIBPAIR software.
Haplotypes were estimated using TDTPHASED in the
UNPHASED package [38] and transmission to affected
and unaffected children tested separately. For phase-cer-
tain haplotypes a conditional logistic regression model
was used, corresponding to the probability of the
offspring conditional upon the parents. When phase was
uncertain, unconditional logistic regression on the full
likelihood of parents and offspring was used instead (see
[39] for the formulations of these likelihoods). Transmit-
ted haplotypes were compared to all untransmitted hap-
lotypes, equivalent to the haplotype-based haplotype
relative risk, while an EM algorithm was used to obtain
maximum-likelihood estimates of case and control paren-
tal haplotype frequencies under both null and alternative
hypotheses.
Abbreviations
VDR vitamin D receptor
VDRE vitamin D responsive element
SNP single nucleotide polymorphism
MALDI-TOF matrix assisted laser desorption ionisation –
time of flight
DSP discordant sib pairs
TDT transmission disequilibrium
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